These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8590531

  • 1. Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study.
    Bellandi F, Cantini F, Pedone T, Palchetti R, Bamoshmoosh M, Dabizzi RP.
    Clin Cardiol; 1995 Nov; 18(11):631-4. PubMed ID: 8590531
    [Abstract] [Full Text] [Related]

  • 2. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F, Dabizzi RP, Cantini F, Natale MD, Niccoli L.
    Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
    [Abstract] [Full Text] [Related]

  • 3. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [Abstract] [Full Text] [Related]

  • 4. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R, Stiels B, Hoebrechts R.
    Am J Cardiol; 1997 Feb 15; 79(4):418-23. PubMed ID: 9052343
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 6. [Intravenous propafenone for conversion of atrial fibrillation in the emergency room].
    Antonelli D, Freedberg NA, Feldman A, Darawsha A, Rosenfeld T.
    Harefuah; 2004 Jul 15; 143(7):471-4, 552, 551. PubMed ID: 15669418
    [Abstract] [Full Text] [Related]

  • 7. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
    [Abstract] [Full Text] [Related]

  • 8. Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
    Bianconi L, Mennuni M.
    Am J Cardiol; 1998 Sep 01; 82(5):584-8. PubMed ID: 9732884
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
    Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S, ERAFT Investigators.
    Am J Cardiol; 2002 Dec 15; 90(12):1300-6. PubMed ID: 12480038
    [Abstract] [Full Text] [Related]

  • 10. Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group.
    Ganau G, Lenzi T.
    J Emerg Med; 1998 Dec 15; 16(3):383-7. PubMed ID: 9610964
    [Abstract] [Full Text] [Related]

  • 11. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study.
    Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE.
    Pacing Clin Electrophysiol; 1998 Nov 15; 21(11 Pt 2):2475-9. PubMed ID: 9825370
    [Abstract] [Full Text] [Related]

  • 12. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    Capucci A, Villani GQ, Aschieri D, Piepoli M.
    Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE.
    Am J Cardiol; 2007 Jun 15; 99(12):1721-5. PubMed ID: 17560882
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset.
    Bianconi L, Boccadamo R, Pappalardo A, Gentili C, Pistolese M.
    Am J Cardiol; 1989 Aug 01; 64(5):335-8. PubMed ID: 2667304
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
    Pritchett EL, Page RL, Carlson M, Undesser K, Fava G, Rythmol Atrial Fibrillation Trial (RAFT) Investigators.
    Am J Cardiol; 2003 Oct 15; 92(8):941-6. PubMed ID: 14556870
    [Abstract] [Full Text] [Related]

  • 16. Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation.
    Botto GL, Bonini W, Broffoni T, Espureo M, Cappelletti G, Lombardi R, Molteni S, Pedraglio E, Ferrari G.
    Pacing Clin Electrophysiol; 1998 Nov 15; 21(11 Pt 2):2480-4. PubMed ID: 9825371
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
    Dogan A, Ergene O, Nazli C, Kinay O, Altinbas A, Ucarci Y, Ergene U, Ozaydin M, Gedikli O.
    Acta Cardiol; 2004 Jun 15; 59(3):255-61. PubMed ID: 15255456
    [Abstract] [Full Text] [Related]

  • 18. Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
    Botto GL, Bonini W, Broffoni T, Molteni S, Lombardi R, Alfieri G, Barone P, Bernasconi G, Ferrari G.
    Pacing Clin Electrophysiol; 1996 Nov 15; 19(11 Pt 2):1939-43. PubMed ID: 8945073
    [Abstract] [Full Text] [Related]

  • 19. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
    Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Della Casa S, Sanguinetti M, Magnani B.
    Ann Intern Med; 1997 Apr 15; 126(8):621-5. PubMed ID: 9103129
    [Abstract] [Full Text] [Related]

  • 20. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D, Costabel JP, Aragon M, Lambardi F, Klein A, Corrales Barbosa A, Trivi M, Giniger A.
    Cardiovasc Ther; 2013 Dec 15; 31(6):377-80. PubMed ID: 23683253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.